Plausible or not? EPO’s Enlarged Board of Appeal leaves us in the dark on post-filed data and inventive step
The EPO’s Enlarged Board of Appeal has attempted to clarify the law concerning the doctrine of ‘plausibility’ and the use of post-filed data to support inventive step. The questions answered are of particular relevance to those in the life science sector.